Literature DB >> 8375046

Total homocysteine in plasma or serum: methods and clinical applications.

P M Ueland1, H Refsum, S P Stabler, M R Malinow, A Andersson, R H Allen.   

Abstract

Total homocysteine is defined as the sum of all homocysteine species in plasma/serum, including free and protein-bound forms. In the present review, we compare and evaluate several techniques for the determination of total homocysteine. Because these assays include the conversion of all forms into a single species by reduction, the redistribution between free and protein-bound homocysteine through disulfide interchange does not affect the results, and total homocysteine can be measured in stored samples. Total homocysteine in whole blood increases at room temperature because of a continuous production and release of homocysteine from blood cells, but artificial increase is low if the blood sample is centrifuged within 1 h of collection or placed on ice. Different methods correlate well, and values between 5 and 15 mumol/L in fasting subjects are considered normal. Total homocysteine in serum/plasma is increased markedly in patients with cobalamin or folate deficiency, and decreases only when they are treated with the deficient vitamin. Total homocysteine is therefore of value for the diagnosis and follow-up of these deficiency states and may compensate for weaknesses of the traditional laboratory tests. In addition, total homocysteine is an independent risk factor for premature cardiovascular diseases. These disorders justify introduction of the total homocysteine assay in the routine clinical chemistry laboratory.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375046

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  91 in total

1.  Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route.

Authors:  Amir Sharabi; Eytan Cohen; Jaqueline Sulkes; Moshe Garty
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 2.  Homocysteine and risk of cardiovascular disease.

Authors:  F Andreotti; F Burzotta; A Manzoli; K Robinson
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

3.  Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.

Authors:  Adriano Sabino; Ana Paula Fernandes; Luciana Moreira Lima; Daniel Dias Ribeiro; Marinez Oliveira Sousa; Maria Elizabeth Rennó de Castro Santos; Ana Paula Lucas Mota; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho
Journal:  J Thromb Thrombolysis       Date:  2007-11-27       Impact factor: 2.300

4.  Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Christine M Albert; Joann E Manson
Journal:  Arch Intern Med       Date:  2009-02-23

5.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  The relation of plasma homocysteine to radiographic knee osteoarthritis.

Authors:  M Fayfman; J Niu; Y Q Zhang; D T Felson; B Sack; P Aliabadi; J Selhub; D J Hunter
Journal:  Osteoarthritis Cartilage       Date:  2008-11-30       Impact factor: 6.576

7.  Three different presentation of same pathophysiology.

Authors:  Algherbawe Mushtak; Fahmi Yousef Khan; Baidaa Aldehwe; Ahmed Abdulrahman Al-Ani
Journal:  Acta Inform Med       Date:  2012-09

8.  Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction.

Authors:  N Weiss; Y Y Zhang; S Heydrick; C Bierl; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 9.  [Folate against hyperhomocysteinemia. A new approach for the prevention and therapy of alcoholism-associated disorders?].

Authors:  S Bleich; K Löffelholz; J Kornhuber
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

10.  Measurement and use of total plasma homocysteine. American Society of Human Genetics/American College of Medical Genetics Test and Transfer Committee Working Group.

Authors: 
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.